Results for tag: "Primary Immune Deficiency Drug"

The Primary Immune Deficiency Drug market is a subset of the Immune Disorders Drugs market, which focuses on drugs used to treat primary immunodeficiencies (PID). PIDs are a group of rare, inherited disorders that affect the body's ability to fight off infections. These drugs are used to replace or supplement the body's natural immune system, allowing it to better fight off infections. Common drugs used to treat PIDs include immunoglobulins, interferons, and monoclonal antibodies. The Primary Immune Deficiency Drug market is highly specialized, with a limited number of drugs available. As such, the market is dominated by a few large pharmaceutical companies. These companies are focused on developing new drugs and treatments for PIDs, as well as improving existing treatments. Some of the major players in the market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more